Skip to main content
Calibr
  • About
    • Institute Leadership
    • Board of Directors
    • Scientific Leaders
  • Research
    • Disease Areas
    • Functional Groups
    • Platforms
  • Partnerships
  • News & Publications
    • News
    • Publications
  • Careers
  • Contact

Scientific Leaders



  • Institute Leadership
  • Board of Directors
  • Scientific Leaders
  • Discovery Research
  • Medicinal Chemistry
  • Pharmacology
  • Translational Sciences

Mitch Hull
Mitch Hull Principal Investigator, High-throughput Screening

mhull@calibr.org

Research Interests:

  • Ultra-High-Throughput Screening (uHTS)
  • Lab Automation
  • LIMS and Automation Software Solutions
  • Automated Assay Optimization and DoE

Kristen Johnson, Ph.D.
Kristen Johnson, Ph.D. Principal Investigator, Biology

kjohnson@calibr.org

Research Interests:

  • Autoimmunity and Inflammation
  • Degenerative disease modification, tissue-specific progenitors and tissue regeneration
  • Drug discovery through disease modeling with iPSCs and phenotypic screening
  • Oncology

Kelli Kuhen, Ph.D.
Kelli Kuhen, Ph.D. Director, Global Health Programs

kkuhen@calibr.org

Research Interests:

  • Global Health
  • Infectious and Neglected Tropical Disease
  • Small Molecule Drug Discovery
  • Phenotypic Screening

Jing Li, Ph.D.
Jing Li, Ph.D. Vice President, Program Management

jli@calibr.org

Research Interests:

  • Metabolic and Cardiovascular Disease
  • Cancer Immunotherapy
  • Autoimmunity and Inflammation
  • Tissue-specific Therapeutic Strategies

Case McNamara, Ph.D.
Case McNamara, Ph.D. Principal Investigator, Infectious Disease

cmcnamara@calibr.org

Research Interests:

  • Infectious and Tropical Disease
  • Small Molecule Drug Discovery

Nikki Rogers, Ph.D.
Nikki Rogers, Ph.D. Associate Director, Alliances

nrogers@calibr.org

Research Interests:

  • Small Molecule Drug Discovery and Phenotypic Screening
  • Metabolic and Cardiovascular Diseasey
  • Degenerative Diseases, Aging & Regenerative Medicine
  • Autoimmune and Inflammatory Disease
  • Tissue-specific Therapeutic Strategies
  • Rare Diseases

Weijun Shen, Ph.D.
Weijun Shen, Ph.D. Principal Investigator, Biology

wshen@calibr.org

Research Interests:

  • Small Molecule Drug Discovery
  • Tissue-specific Therapeutic Strategies
  • Enhancing the Pharmacology of Therapeutic Proteins and Peptides
  • Degenerative Diseases, Aging and Regenerative Medicine
  • Oncology
  • Infectious and Neglected Tropical Disease
  • Metabolic and Cardiovascular Disease
  • Autoimmune and Inflammatory Disease

Travis Young, Ph.D.
Travis Young, Ph.D. Director, Protein Sciences

tyoung@calibr.org

Research Interests:

  • Oncology
  • Metabolic and Cardiovascular Disease
  • Infectious and Neglected Tropical Disease
  • Tissue-specific Therapeutic Strategies
  • Bispecific Antibodies and Engineered T cells
  • Small Molecule Drug Discovery

Arnab K. Chatterjee, Ph.D.
Arnab K. Chatterjee, Ph.D. Vice President, Medicinal Chemistry

achatterjee@calibr.org

Research Interests:

  • Degenerative Diseases, Aging and Regenerative Medicine
  • Oncology
  • Rare Diseases
  • Infectious and Tropical Disease
  • Metabolic and Cardiovascular Disease
  • Autoimmune and Inflammatory Disease
  • Small Molecule Drug Discovery
  • Tissue-specific Therapeutic Strategies
  • Enhancing the Pharmacology of Therapeutic Proteins and Peptides

H. Michael Petrassi, Ph.D.
H. Michael Petrassi, Ph.D. Director, Medicinal Chemistry

mpetrassi@calibr.org

Research Interests:

  • Degenerative Diseases, Aging and Regenerative Medicine
  • Small Molecule Stem Cell Modulation
  • Chemical Chaperones
  • Infectious and Tropical Disease
  • Local and enhanced delivery of small molecules
  • Oncology
  • Rare Diseases

Sean Joseph, Ph.D.
Sean Joseph, Ph.D. Director, Pharmacology

sjoseph@calibr.org

Research Interests:

  • Preclinical and Translational Pharmacology
  • Small and Large Molecule Drug Discovery and Clinical Development
  • Oncology
  • Metabolic and Cardiovascular Disease
  • Autoimmune and Inflammatory Disease
  • Degenerative Diseases, Aging and Regenerative Medicine
  • Infectious and Neglected Tropical Diseases
  • Local and enhanced delivery of small molecules

Vân T.B. Nguyễn-Trần, Ph.D.
Vân T.B. Nguyễn-Trần, Ph.D. Principal Investigator, Pharmacology

vnguyen-tran@calibr.org

Research Interests:

  • Metabolic and Cardiovascular Diseases
  • Regenerative Age-related Diseases
  • Autoimmune and Inflammatory Diseases
  • Pharmacology of Therapeutic Proteins and Peptides

Ashley Woods, Ph.D.
Ashley Woods, Ph.D. Principal Investigator, Pharmacology

awoods@calibr.org

Research Interests:

  • Small Molecule Drug Discovery
  • Enhancing the Pharmacology of Therapeutic Proteins and Peptides
  • Bispecific Antibodies and Engineered T cells
  • Degenerative Diseases, Aging and Regenerative Medicine
  • Oncology
  • Metabolic and Cardiovascular Disease
  • Autoimmune and Inflammatory Disease

Vadim Klyushnichenko, Ph.D.
Vadim Klyushnichenko, Ph.D. Vice President, Pharmaceutical Development & Quality

vklyushnichenko@calibr.org

Research Interests:

  • Disruptive and Innovative Bio/Pharmaceutical Technologies
  • Cell Therapy, Tissue Engineering and Regenerative Medicine
  • Continuous Manufacturing and Operations Excellence
  • International Technology Transfer and Global Supply Chain
  • Stage Gate Strategy for Bio/Pharmaceutical Development and Manufacturing
  • Financial Models for Advanced Bio/Pharmaceutical Production
  • Strategic Planning and Portfolio Management

Leonardo Sahelijo, M.D.
Leonardo Sahelijo, M.D. Vice President, Translational Medicine

lsahelijo@calibr.org

Research Interests:

  • (Ultra-)Rare Genetic Diseases/Orphan Indications
  • Neglected Diseases/Drug Repurposing
  • Pharmacogenomics
  • Novel therapeutic approaches
  • Biomarkers
  • Innovative Trial Designs

John Wisler, Ph.D., DABT
John Wisler, Ph.D., DABT Vice President, Toxicology and Pharmacokinetics

jwisler@calibr.org

Research Interests:

  • Nonclinical Drug Safety Assessment/Development of Small Molecules and Biologics
  • Oncology
  • Metabolic and Cardiovascular Disease
  • Neurologic Disorders
  • Rare Disease/Orphan Drug Development
© 2018 Calibr.   All Rights Reserved.
Privacy | Contact | FCOI Policy